Supplemental Table 1 from DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

Abstract

Histopathological findings in the intestines, bone marrow and lung in the repeated dose study in monkeys